Alcon Long Term Debt 2019-2024 | ALC
Alcon long term debt from 2019 to 2024. Long term debt can be defined as the sum of all long term debt fields.
- Alcon long term debt for the quarter ending June 30, 2024 was $4.550B, a 0.68% decline year-over-year.
- Alcon long term debt for 2023 was $4.594B, a 1.17% increase from 2022.
- Alcon long term debt for 2022 was $4.541B, a 14.5% increase from 2021.
- Alcon long term debt for 2021 was $3.966B, a 0.43% increase from 2020.
| Alcon Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $4,594 |
| 2022 | $4,541 |
| 2021 | $3,966 |
| 2020 | $3,949 |
| 2019 | $3,218 |
| 2018 | $ |
| Alcon Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-06-30 | $4,550 |
| 2024-03-31 | $4,553 |
| 2023-12-31 | $4,676 |
| 2023-09-30 | $4,568 |
| 2023-06-30 | $4,581 |
| 2023-03-31 | $4,584 |
| 2022-12-31 | $4,541 |
| 2022-09-30 | $3,853 |
| 2022-06-30 | $3,883 |
| 2022-03-31 | $3,916 |
| 2021-12-31 | $3,966 |
| 2021-09-30 | $3,976 |
| 2021-06-30 | $3,986 |
| 2021-03-31 | $3,979 |
| 2020-12-31 | $3,949 |
| 2020-09-30 | $3,928 |
| 2020-06-30 | $3,909 |
| 2020-03-31 | $3,157 |
| 2019-12-31 | $3,218 |
| 2019-09-30 | $3,216 |
| 2019-06-30 | $1,751 |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $48.180B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.954B | 28.16 |
| Intuitive Surgical (ISRG) | United States | $175.058B | 99.12 |
| IQVIA Holdings (IQV) | United States | $45.858B | 25.99 |
| Edwards Lifesciences (EW) | United States | $42.144B | 27.01 |
| IDEXX Laboratories (IDXX) | United States | $39.616B | 47.66 |
| DexCom (DXCM) | United States | $27.786B | 39.62 |
| STERIS (STE) | Ireland | $23.777B | 27.74 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.808B | 0.00 |
| Waters (WAT) | United States | $20.560B | 30.65 |
| Hologic (HOLX) | United States | $18.870B | 20.52 |
| Sysmex ADR (SSMXY) | Japan | $12.134B | 38.05 |
| Teleflex (TFX) | United States | $11.552B | 17.96 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 12.76 |
| Globus Medical (GMED) | United States | $9.844B | 27.54 |
| Penumbra (PEN) | United States | $7.859B | 81.58 |
| Glaukos (GKOS) | United States | $7.357B | 0.00 |
| Masimo (MASI) | United States | $6.252B | 33.48 |
| TransMedics (TMDX) | United States | $5.606B | 240.09 |
| Integer Holdings (ITGR) | United States | $4.361B | 25.50 |
| PROCEPT BioRobotics (PRCT) | United States | $4.103B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.848B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.736B | 16.05 |
| Elekta AB (EKTAY) | Sweden | $2.601B | 21.19 |
| Inari Medical (NARI) | United States | $2.519B | 0.00 |
| Veracyte (VCYT) | United States | $2.423B | 150.24 |
| Nihon Kohden (NHNKY) | Japan | $2.287B | 14.23 |
| RxSight (RXST) | United States | $2.086B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.578B | 7.19 |
| OPKO Health (OPK) | United States | $1.172B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.142B | 0.00 |
| Artivion (AORT) | United States | $1.137B | 104.38 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.113B | 19.85 |
| Silk Road Medical (SILK) | United States | $1.102B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.969B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.774B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
| Paragon 28 (FNA) | United States | $0.695B | 0.00 |
| SiBone (SIBN) | United States | $0.693B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| IRadimed (IRMD) | United States | $0.595B | 32.16 |
| AxoGen (AXGN) | United States | $0.576B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.373B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 9.92 |
| Delcath Systems (DCTH) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.300B | 0.00 |
| Inogen (INGN) | United States | $0.291B | 0.00 |
| NeuroPace (NPCE) | United States | $0.231B | 0.00 |
| Nevro (NVRO) | United States | $0.231B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.187B | 13.09 |
| Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.137B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.134B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.90 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
| LENSAR (LNSR) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.030B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.017B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |